Quadriceps strength and endurance in fibrotic idiopathic interstitial pneumonia

Respirology

Volumn 19, Issue 1, 2014, Pages 138-143

  Mendoza, Laura ^a,c   Gogali, Athena ^c   Shrikrishna, Dinesh ^c   Cavada, Gabriel ^b   Kemp, Samuel V ^c   Natanek, Samantha A ^c   Jackson, Abigail S ^c   Polkey, Michael I ^c   Wells, Athol U ^c   Hopkinson, Nicholas S ^c  

^a HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

^c ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

exercise; interstitial lung disease; magnetic stimulation; muscle; pulmonary fibrosis

Indexed keywords

CARBON MONOXIDE; TRANSFER FACTOR;

ADULT; ANTHROPOMETRY; ARTICLE; BREATHING MUSCLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDURANCE; EXERCISE; FEMALE; FEMORAL NERVE; FIBROTIC IDIOPATHIC INTERSTITIAL PNEUMONIA; FORCED VITAL CAPACITY; HUMAN; HUMAN TISSUE; INTERSTITIAL PNEUMONIA; MAGNETIC STIMULATION; MALE; MIDDLE AGED; MUSCLE STRENGTH; NERVE STIMULATION; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE;

EXERCISE; INTERSTITIAL LUNG DISEASE; MAGNETIC STIMULATION; MUSCLE; PULMONARY FIBROSIS;

EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HUMANS; IDIOPATHIC INTERSTITIAL PNEUMONIAS; MALE; MIDDLE AGED; MUSCLE STRENGTH; MUSCLE WEAKNESS; PHYSICAL ENDURANCE; PROGNOSIS; PROSPECTIVE STUDIES; PULMONARY FIBROSIS; QUADRICEPS MUSCLE; VITAL CAPACITY;

EID: 84896517281     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12181     Document Type: Article

References (37)

1. Kelly JL, Elkin SL, Fluxman J, et al. Breathlessness and skeletal muscle weakness in patients undergoing lung health screening in primary care. COPD 2013; 10: 40-54.
2. Shrikrishna D, Patel M, Tanner RJ, et al. Quadriceps wasting and physical inactivity in patients with COPD. Eur. Respir. J. 2012; 40: 1115-1122.
3. Gosker HR, Lencer NHMK, Franssen FME, et al. Striking similarities in systemic factors contributing to decreased exercise capacity in patients with severe chronic heart failure or COPD. Chest 2003; 123: 1416-1424.
4. Hülsmann M, Quittan M, Berger R, et al. Muscle strength as a predictor of long-term survival in severe congestive heart failure. Eur. J. Heart Fail. 2004; 6: 101-107.
5. Gosselink R, Troosters T, Decramer M,. Peripheral muscle weakness contributes to exercise limitation in COPD. Am. J. Respir. Crit. Care Med. 1996; 153: 976-980.
6. Swallow EB, Reyes D, Hopkinson NS, et al. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax 2007; 62: 115-120.
7. Shrikrishna D, Hopkinson NS,. Chronic obstructive pulmonary disease: consequences beyond the lung. Clin. Med. 2012; 12: 71-74.
8. Spruit MA, Thomeer MJ, Gosselink R, et al. Skeletal muscle weakness in patients with sarcoidosis and its relationship with exercise intolerance and reduced health status. Thorax 2005; 60: 32-38.
9. Hamilton AL, Killian KJ, Summers E, et al. Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders. Am. J. Respir. Crit. Care Med. 1995; 152: 2021-2031.
10. Nishiyama O, Taniguchi H, Kondoh Y, et al. Quadriceps weakness is related to exercise capacity in idiopathic pulmonary fibrosis. Chest 2005; 127: 2028-2033.
11. Eaton T, Young P, Milne D, et al. Six-minute walk, maximal exercise tests: reproducibility in fibrotic interstitial pneumonia. Am. J. Respir. Crit. Care Med. 2005; 171: 1150-1157.
12. Latsi PI, du Bois RM, Nicholson AG, et al. Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends. Am. J. Respir. Crit. Care Med. 2003; 168: 531-537.
13. Marciniuk DD, Watts RE, Gallagher CG,. Dead space loading and exercise limitation in patients with interstitial lung disease. Chest 1994; 105: 183-189.
14. Harris-Eze AO, Sridhar G, Clemens RE, et al. Role of hypoxemia and pulmonary mechanics in exercise limitation in interstitial lung disease. Am. J. Respir. Crit. Care Med. 1996; 154: 994-1001.
15. Chetta A, Marangio E, Olivieri D,. Pulmonary function testing in interstitial lung diseases. Respiration 2004; 71: 209-213.
16. Burdon JG, Killian KJ, Jones NL,. Pattern of breathing during exercise in patients with interstitial lung disease. Thorax 1983; 38: 778-784.
17. Hansen JE, Wasserman K,. Pathophysiology of activity limitation in patients with interstitial lung disease. Chest 1996; 109: 1566-1576.
18. Marciniuk DD, Sridhar G, Clemens RE, et al. Lung volumes and expiratory flow limitation during exercise in interstitial lung disease. J. Appl. Physiol. 1994; 77: 963-973.
19. Naji NA, Connor MC, Donnelly SC, et al. Effectiveness of pulmonary rehabilitation in restrictive lung disease. J. Cardiopulm. Rehabil. 2006; 26: 237-243.
20. Nishiyama O, Kondoh Y, Kimura T, et al. Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Respirology 2008; 13: 394-399.
21. Ferreira A, Garvey C, Connors GL, et al. Pulmonary rehabilitation in interstitial lung disease: benefits and predictors of response. Chest 2009; 135: 442-447.
22. Holland AE, Hill CJ, Conron M, et al. Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease. Thorax 2008; 63: 549-554.
23. Swallow EB, Gosker HR, Ward KA, et al. A novel technique for nonvolitional assessment of quadriceps muscle endurance in humans. J. Appl. Physiol. 2007; 103: 739-746.
24. Mendoza L, Gogali A, Shrikrishna D, et al. Quadriceps endurance is reduced in fibrotic idiopathic interstitial pneumonia. Thorax 2009; 64 (Suppl. IV): A44-45.
25. Bradley B, Branley HM, Egan JJ, et al. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax 2008; 63 (Suppl. 5): v1-58.
26. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am. J. Respir. Crit. Care Med. 2002; 165: 277-304.
27. Edwards RH, Young A, Hosking GP, et al. Human skeletal muscle function: description of tests and normal values. Clin. Sci. Mol. Med. 1977; 52: 283-290.
28. Hopkinson NS, Nickol AH, Payne J, et al. Angiotensin converting enzyme genotype and strength in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2004; 170: 395-399.
29. Seymour JM, Spruit MA, Hopkinson NS, et al. The prevalence of quadriceps weakness in COPD and the relationship with disease severity. Eur. Respir. J. 2010; 36: 81-88.
30. Polkey MI, Kyroussis D, Hamnegard CH, et al. Quadriceps strength and fatigue assessed by magnetic stimulation of the femoral nerve in man. Muscle Nerve 1996; 19: 549-555.
31. Hopkinson NS, Man WD, Dayer MJ, et al. Acute effect of oral steroids on muscle function in chronic obstructive pulmonary disease. Eur. Respir. J. 2004; 24: 137-142.
32. Andonopoulos AP, Papadimitriou C, Melachrinou M, et al. Asymptomatic gastrocnemius muscle biopsy: an extremely sensitive and specific test in the pathologic confirmation of sarcoidosis presenting with hilar adenopathy. Clin. Exp. Rheumatol. 2001; 19: 569-572.
33. Swallow EB, Barreiro E, Gosker H, et al. Quadriceps muscle strength in scoliosis. Eur. Respir. J. 2009; 34: 1429-1435.
34. de Troyer A, Yernault JC,. Inspiratory muscle force in normal subjects and patients with interstitial lung disease. Thorax 1980; 35: 92-100.
35. Man WD, Soliman MG, Nikoletou D, et al. Non-volitional assessment of skeletal muscle strength in patients with chronic obstructive pulmonary disease. Thorax 2003; 58: 665-669.
36. Flaherty KR, Andrei AC, Murray S, et al. Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test. Am. J. Respir. Crit. Care Med. 2006; 174: 803-809.
37. du Bois RM, Weycker D, Albera C, et al. Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference. Am. J. Respir. Crit. Care Med. 2011; 183: 1231-1237.